News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
746,041 Results
Type
Article (71634)
Company Profile (259)
Press Release (674148)
Section
Business (208913)
Career Advice (3114)
Deals (35783)
Drug Delivery (121)
Drug Development (84055)
Employer Resources (190)
FDA (17482)
Job Trends (15834)
News (357233)
Policy (35673)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (11)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (1)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2951)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (85)
Alliances (54322)
ALS (93)
Alzheimer's disease (1447)
Antibody-drug conjugate (ADC) (134)
Approvals (17458)
Artificial intelligence (276)
Autoimmune disease (16)
Automation (14)
Bankruptcy (357)
Best Places to Work (12095)
BIOSECURE Act (20)
Biosimilars (110)
Biotechnology (167)
Bladder cancer (64)
Brain cancer (28)
Breast cancer (261)
Cancer (2103)
Cardiovascular disease (174)
Career advice (2629)
Career pathing (33)
CAR-T (157)
Cell therapy (447)
Cervical cancer (19)
Clinical research (67421)
Collaboration (821)
Compensation (318)
Complete response letters (28)
COVID-19 (2796)
CRISPR (43)
C-suite (225)
Cystic fibrosis (105)
Data (1984)
Decentralized trials (2)
Denatured (41)
Depression (48)
Diabetes (257)
Diagnostics (6685)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (46)
Drug discovery (127)
Drug pricing (112)
Drug shortages (29)
Duchenne muscular dystrophy (91)
Earnings (82242)
Editorial (38)
Employer branding (25)
Employer resources (163)
Events (109104)
Executive appointments (676)
FDA (18639)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (738)
Gene editing (108)
Generative AI (28)
Gene therapy (316)
GLP-1 (780)
Government (4873)
Grass and pollen (4)
Guidances (48)
Healthcare (19721)
Huntington's disease (21)
IgA nephropathy (25)
Immunology and inflammation (113)
Indications (27)
Infectious disease (2941)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (90)
Interviews (581)
IPO (16178)
IRA (46)
Job creations (4193)
Job search strategy (2189)
Kidney cancer (10)
Labor market (34)
Layoffs (487)
Leadership (20)
Legal (8408)
Liver cancer (76)
Lung cancer (306)
Lymphoma (137)
Machine learning (4)
Management (64)
Manufacturing (284)
MASH (62)
Medical device (13955)
Medtech (13960)
Mergers & acquisitions (20074)
Metabolic disorders (678)
Multiple sclerosis (76)
NASH (23)
Neurodegenerative disease (91)
Neuropsychiatric disorders (24)
Neuroscience (1965)
NextGen: Class of 2025 (7080)
Non-profit (4898)
Northern California (2319)
Now hiring (38)
Obesity (364)
Opinion (259)
Ovarian cancer (75)
Pain (86)
Pancreatic cancer (78)
Parkinson's disease (139)
Partnered (22)
Patents (216)
Patient recruitment (97)
Peanut (50)
People (59506)
Pharmaceutical (64)
Pharmacy benefit managers (17)
Phase I (20851)
Phase II (29335)
Phase III (22317)
Pipeline (1047)
Podcasts (108)
Policy (125)
Postmarket research (3034)
Preclinical (9417)
Press Release (71)
Prostate cancer (99)
Psychedelics (38)
Radiopharmaceuticals (253)
Rare diseases (386)
Real estate (6496)
Recruiting (75)
Regulatory (24493)
Reports (51)
Research institute (2639)
Resumes & cover letters (490)
Rett syndrome (3)
RNA editing (4)
RSV (46)
Schizophrenia (74)
Series A (130)
Series B (84)
Service/supplier (16)
Sickle cell disease (53)
Southern California (2034)
Special edition (18)
Spinal muscular atrophy (160)
Sponsored (32)
Startups (3869)
State (2)
Stomach cancer (14)
Supply chain (61)
The Weekly (64)
United States (21155)
Vaccines (741)
Venture capitalists (38)
Webinars (13)
Weight loss (258)
Women's health (35)
Worklife (18)
Date
Today (233)
Last 7 days (724)
Last 30 days (2825)
Last 365 days (34363)
2025 (8264)
2024 (35998)
2023 (40741)
2022 (51982)
2021 (56641)
2020 (55569)
2019 (49106)
2018 (37253)
2017 (34827)
2016 (34815)
2015 (40511)
2014 (33947)
2013 (30499)
2012 (31780)
2011 (32116)
2010 (31267)
Location
Africa (1064)
Alabama (55)
Alaska (7)
Arizona (213)
Arkansas (14)
Asia (45040)
Australia (7907)
California (5352)
Canada (1862)
China (492)
Colorado (248)
Connecticut (271)
Delaware (133)
Europe (102206)
Florida (831)
Georgia (199)
Hawaii (1)
Idaho (60)
Illinois (533)
India (27)
Indiana (297)
Iowa (8)
Japan (145)
Kansas (105)
Kentucky (23)
Louisiana (10)
Maine (63)
Maryland (857)
Massachusetts (4078)
Michigan (225)
Minnesota (382)
Mississippi (2)
Missouri (83)
Montana (31)
Nebraska (25)
Nevada (56)
New Hampshire (69)
New Jersey (1615)
New Mexico (31)
New York (1580)
North Carolina (981)
North Dakota (8)
Northern California (2319)
Ohio (197)
Oklahoma (15)
Oregon (37)
Pennsylvania (1208)
Puerto Rico (10)
Rhode Island (26)
South America (1398)
South Carolina (19)
South Dakota (1)
Southern California (2034)
Tennessee (92)
Texas (828)
Utah (168)
Virginia (136)
Washington D.C. (61)
Washington State (529)
West Virginia (3)
Wisconsin (56)
746,041 Results for "edb singapore and agency for science technology and research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
March 25, 2025
·
6 min read
Press Releases
A*STAR And MojiaBio To Develop Next-gen Sustainable Biomanufacturing Platform In Singapore
February 28, 2025
·
7 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
NUS researchers develop microneedle technology to accelerate diabetic wound healing
March 26, 2025
·
5 min read
Genetown
Ora and Singapore Eye Research Institute Unveil Groundbreaking Partnership to Propel Ophthalmology Innovation Globally
Ora, Inc., the foremost global ophthalmology contract research organization, announced a strategic, exclusive partnership with the Singapore Eye Research Institute, a world-renowned institution for cutting-edge eye research and ophthalmic preclinical studies.
May 2, 2024
·
6 min read
Press Releases
AAVantgarde and TIGEM Publish Groundbreaking Research in Science Advances
March 31, 2025
·
2 min read
Press Releases
Caris Life Sciences to Highlight Research at 2025 SGO Annual Meeting on Women’s Cancer
March 11, 2025
·
3 min read
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
News
PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing
October 11, 2024
·
5 min read
Press Releases
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
January 8, 2025
·
5 min read
1 of 74,605
Next
